错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Statistical analysis plan for a cluster randomised controlled trial to compare screening, feedback and intervention for child anxiety problems to usual school practice: identifying Child Anxiety Through Schools-identification to intervention (iCATS-i2i)

  • Susan Ball,
  • Tessa Reardon,
  • Cathy Creswell,
  • Lucy Taylor,
  • Paul Brown,
  • Tamsin Ford,
  • Alastair Gray,
  • Claire Hill,
  • Bec Jasper,
  • Michael Larkin,
  • Ian Macdonald,
  • Fran Morgan,
  • Jack Pollard,
  • Michelle Sancho,
  • Falko F. Sniehotta,
  • Susan H. Spence,
  • Jason Stainer,
  • Paul Stallard,
  • Mara Violato,
  • Obioha C. Ukoumunne

摘要

Background

The Identifying Child Anxiety Through Schools-identification to intervention (iCATS-i2i) trial is being conducted to establish whether ‘screening and intervention’, consisting of usual school practice plus a pathway comprising screening, feedback and a brief parent-led online intervention (OSI: Online Support and Intervention for child anxiety), bring clinical and health economic benefits compared to usual school practice and assessment only — ‘usual school practice’, for children aged 8–9 years in the following: (1) the ‘target population’, who initially screen positive for anxiety problems according to a two-item parent-report child anxiety questionnaire — iCATS-2, and (2) the ‘total population’, comprising all children in participating classes. This article describes the detailed statistical analysis plan for the trial.

Methods and design

iCATS-i2i is a definitive, superiority, pragmatic, school-based cluster randomised controlled trial (with internal pilot), with two parallel groups. Schools are randomised 1:1 to receive either screening and intervention or usual school practice. This article describes the following: trial objectives and outcomes; statistical analysis principles, including detailed estimand information necessary for aligning trial objectives, conduct, analyses and interpretation when there are different analysis populations and outcome measures to be considered; and planned main analyses, sensitivity and additional analyses.

Trial registration

ClinicalTrials.gov ISRCTN76119074. Registered on 4 January 2022